To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-06-30
Target enrollment:
Participant gender:
Summary
Phase 1 study to assess the pharmacokinetic availability and safety and tolerability profile of one such ayurvedic preparation which contains 5 mg THC:CBD 1:1 preparation. Other than the PK profile, we will also be studying its effect on gene expression profiling of the breast and head neck oral cavity squamous cell carcinoma tissue.